A new coronavirus associated with human respiratory disease in China

Wu, Fan, Zhao, Su, Yu, Bin, Chen, Yan-Mei, Wang, Wen, Song, Zhi-Gang, Hu, Yi, Tao, Zhao-Wu +11 more·2020·Nature
DOI 10.1038/s41586-020-2008-3

Cited by (1,042)

Items 801–900 of 1,042

  1. Prevalence and Persistent Shedding of Fecal SARS-CoV-2 RNA in Patients With COVID-19 Infection: A Systematic Review and Meta-analysis
    Yawen Zhang, Mengsha Cen, Mengjia Hu, Lijun Du, Weiling Hu, John J. Kim, Ning Dai · 2021 · Clinical and Translational Gastroenterology
  2. Bat origin of a new human coronavirus: there and back again
    Xiang Li, Yuhe Song, Gary Wong, Jie Cui · 2020 · Science China Life Sciences
  3. COVID-19 challenge for modern medicine
    Tomasz Dzieciątkowski, Łukasz Szarpak, Krzysztof Jerzy Filipiak, Milosz Jaroslaw Jaguszewski, Jerzy Robert Ładny, Jacek Smereka · 2020 · Cardiology Journal
  4. Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals
    Daniel W. Kneller, Stephanie S. Galanie, G.N. Phillips, Hugh O’Neill, Leighton Coates, Andrey Y. Kovalevsky · 2020 · Structure
  5. Molecular docking analysis of rutin reveals possible inhibition of SARS-CoV-2 vital proteins
    Fazlur Rahman, Shams S. M. Tabrez, Rahat Azhar Ali, Ali Saeed Alqahtani, Mohammad Z. Ahmed, Abdur Rub · 2021 · Journal of Traditional and Complementary Medicine
  6. Structural basis for backtracking by the SARS-CoV-2 replication–transcription complex
    Brandon Malone, James Chen, Qi Wang, Eliza Llewellyn, Young Joo Choi, Paul Dominic B. Olinares, Xinyun Cao, Carolina Hernández, Edward T. Eng, Brian T. Chait et al. · 2021 · Proceedings of the National Academy of Sciences
  7. Host traits shape virome composition and virus transmission in wild small mammals
    Yanmei Chen, Shu-Jian Hu, Xian‐Dan Lin, Jun-Hua Tian, Jia-Xin Lv, Miao-Ruo Wang, Xiu-Qi Luo, Yuan-Yuan Pei, Ruixue Hu, Zhigang Song et al. · 2023 · Cell
  8. The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy
    Ranjan K. Mohapatra, Lucia Pintilie, Venkataramana Kandi, Ashish Kumar Sarangi, Debadutta Das, Raghaba Sahu, Lina O. Perekhoda · 2020 · Chemical Biology & Drug Design
  9. Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases
    Banoth Karan Kumar, Faheem Faheem, Kondapalli Venkata Gowri Chandra Sekhar · 2020 · Journal of Biomolecular Structure and Dynamics
  10. Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs
    Maryam Hosseini, Wanqiu Chen, Daliao Xiao, Charles Wang · 2021 · Precision Clinical Medicine
  11. Zoonotic disease and virome diversity in bats
    Kate Van Brussel, Edward Charles Holmes · 2021 · Current Opinion in Virology
  12. Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease
    Daniel W. Kneller, Hui Li, Gwyndalyn Phillips, Kevin L. Weiss, Qiu Zhang, Mark A. Arnould, Colleen B. Jonsson, Surekha Surendranathan, Jyothi Parvathareddy, Matthew Paul Blakeley et al. · 2022 · Nature Communications
  13. COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations
    Flaherty, Gerard Thomas, Hession, Paul, Liew, Chee Hwui, Lim, Bryan Chang Wei, Leong, Tan Kok, Lim, Victor, Sulaiman, Lokman Hakim · 2020 · Tropical Diseases, Travel Medicine and Vaccines
  14. Gastrointestinal and Liver Manifestations of COVID-19
    Amol Agarwal, Alan Chen, Nishal Ravindran, Chau To, Paul Joseph Thuluvath · 2020 · Journal of Clinical and Experimental Hepatology
  15. Downregulated Gene Expression Spectrum and Immune Responses Changed During the Disease Progression in Patients With COVID-19
    Yabo Ouyang, Jiming Yin, Wenjing Wang et al. · 2020 · Clinical Infectious Diseases
  16. Involvement of the Nervous System in SARS-CoV-2 Infection
    Hao Li, Qun Xue, Xingshun Xu · 2020 · Neurotoxicity Research
  17. The cGAS‐STING pathway: The role of self‐DNA sensing in inflammatory lung disease
    Ruihua Ma, Tatiana P. Ortiz Serrano, Jennifer Davis, Andrew D. Prigge, Karen M. Ridge · 2020 · The FASEB Journal
  18. Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives
    Balasubramanian Ganesh, Thangarasu Rajakumar, Malathi Mathiyazhakan, Manikandan Natesan, Nagaraj Jaganathasamy, Santhakumar Aridoss, Elangovan Arumugam, Yashpal Singh Malik · 2021 · Clinical Epidemiology and Global Health
  19. SARS-CoV-2 nucleocapsid protein phase separates with G3BPs to disassemble stress granules and facilitate viral production
    Lingling Luo, Zhean Li, Tiejun Zhao et al. · 2021 · 中国科学通报：英文版
  20. Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2
    Ewelina Węglarz‐Tomczak, Jakub M. Tomczak, Michał Talma, Małgorzata Burda‐Grabowska, Mirosław Giurg, Stanley Brul · 2021 · Scientific Reports
  21. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice
    Jianxiong Zeng, Xiaochun Xie, Xiaoli Feng, Ling Xu, Jian-Bao Han, Dandan Yu, Qing‐Cui Zou, Qianjin Liu, Xiaohong Li, Guanqin Ma et al. · 2021 · EBioMedicine
  22. Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19
    Canrong Wu, Wanchao Yin, Yi Jiang, H. Eric Xu · 2022 · Acta Pharmacologica Sinica
  23. BioAider: An efficient tool for viral genome analysis and its application in tracing SARS-CoV-2 transmission
    Zhijian Zhou, Ye Qiu, Ying Dong Pu · 2020 · Sustainable Cities and Society
  24. Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19
    Şevki Adem, Volkan Eyüpoğlu, Iqra Sarfraz, Azhar Rasul, Ameer Fawad Zahoor, Muhammad Ali, Mohnad Abdalla, Ibrahim M. Ibrahim, Abdo A. Elfiky · 2020 · Phytomedicine
  25. Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
    Fei Yu, Rong Xiang, Xiaoqian Deng, Lili Wang, Zhengsen Yu, Shijun Tian, Ruiying Liang, Yanbai Li, Tianlei Ying, Shibo Jiang · 2020 · Signal Transduction and Targeted Therapy
  26. SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms
    Christine Vazquez, Sydnie Swanson, Seble G. Negatu, Mark Dittmar, Jesse Miller, Holly R. Ramage, Sara R. Cherry, Kellie A. Jurado · 2021 · PLoS ONE
  27. 3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents
    Sho Konno, Kiyotaka Kobayashi, Miki Senda, Yuta Funai, Yuta Seki, Ikumi Tamai, Laura Schäkel, Kyousuke Sakata, Thanigaimalai Pillaiyar, Akihiro Taguchi et al. · 2021 · Journal of Medicinal Chemistry
  28. The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations
    Ryan Joyce, Vivian W. Hu, Jun Wang · 2022 · Medicinal Chemistry Research
  29. Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV
    Rui Li, Songlin Qiao, Gaiping Zhang · 2020 · Journal of Infection
  30. In Silico Drug Repurposing for SARS-CoV‑2 Main Proteinase and Spike Proteins
    Irene Maffucci, Alessandro Contini · 2020 · Journal of Proteome Research
  31. UMAP-assisted K-means clustering of large-scale SARS-CoV-2 mutation datasets
    Yuta Hozumi, Rui Wang, Changchuan Yin · 2021 · Computers in Biology and Medicine
  32. Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins
    Yajuan Rui, Jiaming Su, Si Shen, Ying Hu, Dingbo Huang, Wenwen Zheng, Meng Lou, Yifei Shi, Meng Wang, Shiqi Chen et al. · 2021 · Signal Transduction and Targeted Therapy
  33. COVID ‐19 in children. II : Pathogenesis, disease spectrum and management
    Annaleise R. Howard‐Jones, David Paul Burgner, Nigel W. Crawford et al. · 2021 · Journal of Paediatrics and Child Health
  34. Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19
    Jiantao Zhang, Amara Ejikemeuwa, Volodymyr Gerzanich, Mohamed Nasr, Qiyi Tang, J. Marc Simard, Yuqi Zhao · 2022 · Frontiers in Microbiology
  35. SARS‐CoV‐2 spike protein favors ACE2 from Bovidae and Cricetidae
    Junwen Luan, Xiaolu Jin, Yue Lu, Leiliang Zhang · 2020 · Journal of Medical Virology
  36. Clinical Insights into the Gastrointestinal Manifestations of COVID-19
    Jonathan J. Kopel, Abhilash Perisetti, Mahesh Gajendran, Umesha Naragalu Boregowda, Hemant Goyal · 2020 · Digestive Diseases and Sciences
  37. Intestinal Flora as a Potential Strategy to Fight SARS-CoV-2 Infection
    Lihong He, Longfei Ren, Junfeng Li, Yong-Na Wu, Xun� Li, Lei Zhang · 2020 · Frontiers in Microbiology
  38. Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19
    Jun Chen, Lu Xia, Li Liu et al. · 2020 · Open Forum Infectious Diseases
  39. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses
    Rajanish Giri, Taniya Bhardwaj, Meenakshi Shegane, Bhuvaneshwari R. Gehi, Prateek Kumar, Kundlik Gadhave, Christopher J. Oldfield, Vladimir Nikolaevich Uversky · 2020 · Cellular and Molecular Life Sciences
  40. The role of Interleukin 6 inhibitors in therapy of severe COVID-19
    Evgeny Lvovich Nasonov, Samsonov MIu · 2020 · Biomedicine & Pharmacotherapy
  41. Pathophysiology and treatment strategies for COVID-19
    Manoj Kumar, Souhaila Al Khodor · 2020 · Journal of Translational Medicine
  42. Evidence of Long-Distance Droplet Transmission of SARS-CoV-2 by Direct Air Flow in a Restaurant in Korea
    Keun Sang Kwon, Jung-Im Park, Young-Joon Park, Don-Myung Jung, Ki-Wahn Ryu, Ju Hyung Lee · 2020 · Journal of Korean Medical Science
  43. A novel artificial intelligence-assisted triage tool to aid in the diagnosis of suspected COVID-19 pneumonia cases in fever clinics
    Cong Feng, Lili Wang, Xin Chen, Yongzhi Zhai, Feng Zhu, Chen Hua, Yingchan Wang, Xiangzheng Su, Sai Huang, Lin Hai Tian et al. · 2021 · Annals of Translational Medicine
  44. Impact of COVID-19 pandemic on chronic diseases care follow-up and current perspectives in low resource settings: a narrative review.
    Ginenus Fekadu, Firomsa Bekele, Tadesse Tolossa, Getahun Fetensa, Ebisa Turi, Motuma Getachew, Eba Abdisa, Lemessa Assefa, Melkamu Afeta, Waktole Demisew et al. · 2021 · PubMed Central
  45. Genomic characterization and phylogenetic analysis of SARS‐COV‐2 in Italy
    Gianguglielmo Zehender, Alessia Lai, Annalisa Bergna, Luca Meroni, Agostino Riva, Claudia Balotta, Maciej Tarkowski, Arianna Gabrieli, Dario Bernacchia, Stefano Rusconi et al. · 2020 · Journal of Medical Virology
  46. COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies
    Abdur Rauf, Tareq Abu‐Izneid, Ahmed Olatunde, Anees Ahmed Khalil, Fahad Abdulrahman Alhumaydhi, Tabussam Tufail, Mohammad Ali Shariati, Максим Борисович Ребезов, Zainab M. Almarhoon, Yahia N. Mabkhot et al. · 2020 · International Journal of Environmental Research and Public Health
  47. One Year of SARS-CoV-2: How Much Has the Virus Changed?
    Santiago Vilar, Daniel G. Isom · 2021 · Biology
  48. Neutralizing Aptamers Block S/RBD‐ACE2 Interactions and Prevent Host Cell Infection
    Xiaohui Liu, Yi‐ling Wang, Jacky Wu, Jianjun Qi, Zihua Zeng, Quanyuan Wan, Zhenghu Chen, Pragya Manandhar, Victoria S. Cavener, Nina R. Boyle et al. · 2021 · Angewandte Chemie International Edition
  49. GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein
    Ming Zhao, Yu Yu, Li-Ming Sun, Jia‐Qing Xing, Tingting Li, Yunkai Zhu, Miao Wang, Yin Yu, Wen Xue, Tian Xia et al. · 2021 · Nature Communications
  50. Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases
    Xingchen Pan, David M. Ojcius, Tianyue Gao, Zhongsheng Li, Chunhua Pan, Chungen Pan · 2020 · Microbes and Infection
  51. COVID-19 infection prevalence in pediatric population: Etiology, clinical presentation, and outcome
    Fahad Alsohime, Mohamad-Hani A. Temsah, Abdulrahman M. Alnemri, Ali M. Somily, Sarah Alsubaie · 2020 · Journal of Infection and Public Health
  52. Potential of graphene-based materials to combat COVID-19: properties, perspectives, and prospects
    Avanish Kumar Srivastava, Neeraj Dwivedi, Chetna Dhand, Raju Khan, N. Sathish, Manoj Kumar Gupta, Rajeev Kumar, Surender Kumar · 2020 · Materials Today Chemistry
  53. “Fast deep learning computer-aided diagnosis of COVID-19 based on digital chest x-ray images”
    Mugahed A. Al–antari, Cam-Hao Hua, Jaehun Bang, Sungyoung Lee · 2020 · Applied Intelligence
  54. An overview of the effect of bioaerosol size in coronavirus disease 2019 transmission
    Marcelo I. Guzmán · 2020 · The International Journal of Health Planning and Management
  55. Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response
    Jingwen Lin, Chao Tang, Han-cheng Wei, Baowen Du, Chuan Chen, Minjin Wang, Yongzhao Zhou, Mingxia Yu, Lu Cheng, Suvi H. Kuivanen et al. · 2021 · Cell Host & Microbe
  56. Next-Generation Sequencing (NGS) in COVID-19: A Tool for SARS-CoV-2 Diagnosis, Monitoring New Strains and Phylodynamic Modeling in Molecular Epidemiology
    Goldin John, Nikhil Sahajpal, Ashis Kumar Mondal, Sudha Ananth, Colin Williams, Alka Chaubey, Amyn M. Rojiani, Ravindra B Kolhe · 2021 · Current Issues in Molecular Biology
  57. Origin and evolutionary analysis of the SARS-CoV-2 Omicron variant
    Yamin Sun, Wenchao Lin, Wei Dong, Jianguo Xu · 2021 · Journal of Biosafety and Biosecurity
  58. Flavonoids Activation of the Transcription Factor Nrf2 as a Hypothesis Approach for the Prevention and Modulation of SARS-CoV-2 Infection Severity
    Patricia Mendonca, Karam F. A. Soliman · 2020 · Antioxidants
  59. Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic
    Andy Ngo, Debra Masel, Christine M. Cahill, Neil Blumberg, Majed A. Refaai · 2020 · Clinics in Laboratory Medicine
  60. Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene
    Filipe Pereira · 2020 · Infection Genetics and Evolution
  61. COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
    Institut Curie Breast Cancer and COVID Group, Perrine Vuagnat, Maxime Frélaut et al. · 2020 · Breast Cancer Research
  62. Coronavirus Disease (COVID-19): A Machine Learning Bibliometric Analysis
    Francesca De Felice, Antonella Polimeni · 2020 · In Vivo
  63. SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway
    Grant R. Campbell, Rachel K. To, Jonathan Hanna, Stephen A. Spector · 2021 · iScience
  64. Corona Virus Disease 2019, a growing threat to children?
    Pu Yang, Liu Pin, Dan Li, Dongchi Zhao · 2020 · Journal of Infection
  65. Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
    Rudra P. Saha, Ashish Ranjan Sharma, Manoj Kumar Singh, Saikat Samanta, Swarnav Bhakta, Snehasish Mandal, Manojit Bhattacharya, Sang Soo Lee, Chiranjib Chakraborty · 2020 · Frontiers in Pharmacology
  66. Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media, Nucleic Acid Extraction Reagents, Detergents, and Fixatives
    Stephen R. Welch, Katherine A. Davies, Hubert Buczkowski, Nipunadi Hettiarachchi, Nicole Green, Ulrike Arnold, Matthew Jones, Matthew J. Hannah, Reah Evans, Christopher Burton et al. · 2020 · Journal of Clinical Microbiology
  67. GenASM: A High-Performance, Low-Power Approximate String Matching Acceleration Framework for Genome Sequence Analysis
    Damla Senol Cali, Gurpreet Singh Kalsi, Zülal Bingöl, Can Fırtına, Lavanya Subramanian, Jeremie S. Kim, Rachata Ausavarungnirun, Mohammed Alser, Juan Gómez-Luna, Amirali Boroumand et al. · 2020 · IEEE/ACM International Symposium on Microarchitecture (MICRO)
  68. Coronavirus replication–transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit
    Heiko Slanina, Ramakanth Madhugiri, Ganesh Bylapudi · 2021 · Proceedings of the National Academy of Sciences
  69. Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review
    Douglas Xavier-Santos, Marina Padilha, Giovanna Alexandre Fabiano, Gabriel Vinderola, Adriano Gomes da Cruz, Kátia Sivieri, Adriane Elisabete Costa Antunes · 2022 · Trends in Food Science & Technology
  70. Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease
    G.D. Noske, Ellen de Souza Silva, Mariana Ortiz de Godoy, Isabela Dolci, R.S. Fernandes, Rafael V. C. Guido, Peter Sjö, Glaucius Oliva, Andre Schutzer Godoy · 2023 · Journal of Biological Chemistry
  71. Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2
    Sun, Shihui, Gu, Hongjing, Cao, Lei, Chen, Qi, Ye, Qing, Yang, Guan, Li, Rui-Ting, Fan, Hang, Deng, Yong-Qiang, Song, Xiaopeng et al. · 2021 · Nature Communications
  72. Scientific research progress of COVID‐19/SARS‐CoV‐2 in the first five months
    Hua Li, Zhe Liu, Junbo Ge · 2020 · Journal of Cellular and Molecular Medicine
  73. Occurrence of Antibodies against SARS-CoV-2 in the Domestic Cat Population of Germany
    Anna Michelitsch, Donata Hoffmann, Kerstin Wernike · 2020 · Vaccines
  74. In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS‐CoV ‐2 main protease ( 3CLpro )
    Abbas Khan, Wang Heng, Yanjing Wang, Jingfei Qiu, Xiao-Yong Wei, Shaoliang Peng, Shoaib Saleem, Mazhar Khan, Syed Shujait Ali, Dong‐Qing Wei · 2021 · Phytotherapy Research
  75. Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy
    Claudia Alteri, Valeria Cento, Antonio Piralla, Valentino Costabile, Monica Tallarita, Luna Colagrossi, Silvia Renica, Federica Giardina, Federica Novazzi, Stefano Gaiarsa et al. · 2021 · Nature Communications
  76. Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates
    Linling He, Xiaohe Lin, Ying Wang, Ciril Abraham, Cindy Sou, Timothy Ngo, Yi Zhang, Ian A. Wilson, Jiang Zhu · 2021 · Science Advances
  77. Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets
    Nunziata Maio, Bernard A. P. Lafont, Debangsu Sil, Yan Li, Joseph Martin Bollinger Jr., Carsten Krebs, Theodore C. Pierson, William Marston Linehan, Tracey Ann Rouault · 2021 · Science
  78. Reliability of Google Trends: Analysis of the Limits and Potential of Web Infoveillance During COVID-19 Pandemic and for Future Research
    Alessandro Rovetta · 2021 · Frontiers in Research Metrics and Analytics
  79. Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives
    Jonathan P. Rogers, Cameron James Watson, James Badenoch, Benjamin Cross, Matthew Butler, Jia Song, Danish Hafeez, Hamilton Morrin, Emma Rachel Rengasamy, Lucretia Thomas et al. · 2021 · Journal of Neurology Neurosurgery & Psychiatry
  80. X-ray and CT-scan-based automated detection and classification of covid-19 using convolutional neural networks (CNN)
    Samritika Thakur, Aman Kumar · 2021 · Biomedical Signal Processing and Control
  81. Recurrent SARS-CoV-2 mutations in immunodeficient patients
    Samuel Wilkinson, Alex Richter, Anna Casey, Husam Kamal Eldin Osman, Jeremy D. Mirza, Joanne Stockton, Josh Quick, Liz Ratcliffe, Natalie Sparks, Nicola Cumley et al. · 2022 · Virus Evolution
  82. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal
    Jacques Fantini, Henri Chahinian, Nouara Yahi · 2020 · International Journal of Antimicrobial Agents
  83. COVID-19, Virology and Geroscience: A Perspective
    Camille Vellas, Pierre Delobel, Philipe de Souto Barreto, Jacques Izopet · 2020 · The journal of nutrition health & aging
  84. SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine
    Prabhat Pratap Singh Tomar, Isaiah Tuvia Arkin · 2020 · Biochemical and Biophysical Research Communications
  85. Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2
    Alex Renn, Ying Fu, Xin Hu, Matthew D. Hall, Anton M. Simeonov · 2020 · Trends in Pharmacological Sciences
  86. SARS-CoV-2 samples may escape detection because of a single point mutation in the N gene
    Katharina Ziegler, Philipp A. Steininger, Renate Ziegler · 2020 · Eurosurveillance
  87. Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
    Sho Iketani, F. Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair, Arie Zask, Yaoxing Huang, Xing Li, Brent R. Stockwell et al. · 2021 · Nature Communications
  88. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review
    SeyedAhmad SeyedAlinaghi, Pegah Mirzapour, Omid Dadras, Zahra Pashaei, Amirali Karimi, Mehrzad MohsseniPour, Mahdi Soleymanzadeh, Alireza Barzegary, Amir Masoud Afsahi, Farzin Vahedi et al. · 2021 · European journal of medical research
  89. Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection
    Chrispin Chaguza, Anne Maria Hahn, Mary E. Petrone, Shuntai Zhou, David J. P. Ferguson, Mallery I. Breban, Kien Pham, Mario A. Peña-Hernández, Christopher Castaldi, Verity Hill et al. · 2023 · Cell Reports Medicine
  90. Approaches and Challenges in SARS-CoV-2 Vaccine Development
    Dagotto, Gabriel, Yu, Jingyou, Barouch, Dan H. · 2020 · Cell Host & Microbe
  91. Present variants of concern and variants of interest of severe acute respiratory syndrome coronavirus 2: Their significant mutations in S‐glycoprotein, infectivity, re‐infectivity, immune escape and vaccines activity
    Chakraborty, Chiranjib, Bhattacharya, Manojit, Sharma, Ashish Ranjan · 2022 · Reviews in Medical Virology
  92. COVID-19 no estado do Ceará, Brasil: comportamentos e crenças na chegada da pandemia
    Danilo Lopes Ferreira Lima, Aldo Angelim Dias, Renata Sabóia Rabelo, Igor Demes da Cruz, Samuel Carvalho Costa, Flávia Maria Noronha Nigri, Jiovanne Rabelo Neri · 2020 · Ciência & Saúde Coletiva
  93. The important role of polysaccharides from a traditional Chinese medicine-Lung Cleansing and Detoxifying Decoction against the COVID-19 pandemic
    Peng Cao, Sanlan Wu, Tingting Wu, Yahui Deng, Qilin Zhang, Kaiping Wang, Yu Zhang · 2020 · Carbohydrate Polymers
  94. Molecular Basis for ADP-Ribose Binding to the Mac1 Domain of SARS-CoV-2 nsp3
    David N. Frick, Rajdeep S. Virdi, Nemanja Vuksanovic, Narayan Dahal, Nicholas R. Silvaggi · 2020 · Biochemistry
  95. High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity
    Jinghua Lu, Peter D. Sun · 2020 · Journal of Biological Chemistry
  96. Text mining approaches for dealing with the rapidly expanding literature on COVID-19
    Lucy Lu Wang, Kyle Lo · 2020 · Briefings in Bioinformatics
  97. Botanical drugs and supplements affecting the immune response in the time of COVID ‐19: Implications for research and clinical practice
    Thomas Brendler, Ahmed Al‐Harrasi, Rudolf Bauer, Stefan Gafner, Mary L Hardy, Michael Heinrich, Hossein Hosseinzadeh, Angelo Antonio Izzo, Martin Michaelis, Marjan Nassiri‐Asl et al. · 2020 · Phytotherapy Research
  98. DeepCoroNet: A deep LSTM approach for automated detection of COVID-19 cases from chest X-ray images
    Fatih Demir · 2021 · Applied Soft Computing
  99. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro
    Martina Morokutti-Kurz, Maria Fröba, Philipp Graf, Maximilian Große, Andreas Grassauer, Janina Auth, Ulrich Schubert, Eva Prieschl‐Grassauer · 2021 · PLoS ONE
  100. Role of Mitochondria in Viral Infections
    Srikanth Elesela, Nicholas W. Lukacs · 2021 · Life